307 related articles for article (PubMed ID: 18052256)
1. Mechanism of inhibition of HIV-1 reverse transcriptase by the novel broad-range DNA polymerase inhibitor N-{2-[4-(aminosulfonyl)phenyl]ethyl}-2-(2-thienyl)acetamide.
Herschhorn A; Oz-Gleenberg I; Hizi A
Biochemistry; 2008 Jan; 47(1):490-502. PubMed ID: 18052256
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
[TBL] [Abstract][Full Text] [Related]
3. Polycitone A, a novel and potent general inhibitor of retroviral reverse transcriptases and cellular DNA polymerases.
Loya S; Rudi A; Kashman Y; Hizi A
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):85-92. PubMed ID: 10548537
[TBL] [Abstract][Full Text] [Related]
4. Virtual screening, identification, and biochemical characterization of novel inhibitors of the reverse transcriptase of human immunodeficiency virus type-1.
Herschhorn A; Hizi A
J Med Chem; 2008 Sep; 51(18):5702-13. PubMed ID: 18800765
[TBL] [Abstract][Full Text] [Related]
5. 3,5,8-Trihydroxy-4-quinolone, a novel natural inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
Loya S; Rudi A; Tal R; Kashman Y; Loya Y; Hizi A
Arch Biochem Biophys; 1994 Mar; 309(2):315-22. PubMed ID: 7510944
[TBL] [Abstract][Full Text] [Related]
6. Differences in the inhibition of human immunodeficiency virus type 1 reverse transcriptase DNA polymerase activity by analogs of nevirapine and [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1", 2"-oxathiole-2",2"-dioxide] (TSAO).
Arion D; Fletcher RS; Borkow G; Camarasa MJ; Balzarini J; Dmitrienko GI; Parniak MA
Mol Pharmacol; 1996 Nov; 50(5):1057-64. PubMed ID: 8913335
[TBL] [Abstract][Full Text] [Related]
7. Pyrrolobenzothiazepinones and pyrrolobenzoxazepinones: novel and specific non-nucleoside HIV-1 reverse transcriptase inhibitors with antiviral activity.
Campiani G; Nacci V; Fiorini I; De Filippis MP; Garofalo A; Greco G; Novellino E; Altamura S; Di Renzo L
J Med Chem; 1996 Jul; 39(14):2672-80. PubMed ID: 8709096
[TBL] [Abstract][Full Text] [Related]
8. 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro.
Tramontano E; Esposito F; Badas R; Di Santo R; Costi R; La Colla P
Antiviral Res; 2005 Feb; 65(2):117-24. PubMed ID: 15708638
[TBL] [Abstract][Full Text] [Related]
9. De novo parallel design, synthesis and evaluation of inhibitors against the reverse transcriptase of human immunodeficiency virus type-1 and drug-resistant variants.
Herschhorn A; Lerman L; Weitman M; Gleenberg IO; Nudelman A; Hizi A
J Med Chem; 2007 May; 50(10):2370-84. PubMed ID: 17458947
[TBL] [Abstract][Full Text] [Related]
10. Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs).
Hang JQ; Li Y; Yang Y; Cammack N; Mirzadegan T; Klumpp K
Biochem Biophys Res Commun; 2007 Jan; 352(2):341-50. PubMed ID: 17113568
[TBL] [Abstract][Full Text] [Related]
11. Partial selective inhibition of HIV-1 reverse transcriptase and human DNA polymerases γ and β by thiated 3'-fluorothymidine analogue 5'-triphosphates.
Wińska P; Miazga A; Poznański J; Kulikowski T
Antiviral Res; 2010 Nov; 88(2):176-81. PubMed ID: 20739003
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of HIV-1 reverse transcriptase (HIV-1 RT) RNase H by small RNA hairpins and dumbbells.
Hannoush RN; Carriero S; Min KL; Damha MJ
Chembiochem; 2004 Apr; 5(4):527-33. PubMed ID: 15185377
[TBL] [Abstract][Full Text] [Related]
13. Linked lexitropsins and the in vitro inhibition of HIV-1 reverse transcriptase RNA-directed DNA polymerization: a novel induced-fit of 3,5 m-pyridyl bisdistamycin to enzyme-associated template-primer.
Filipowsky ME; Kopka ML; Brazil-Zison M; Lown JW; Dickerson RE
Biochemistry; 1996 Dec; 35(48):15397-410. PubMed ID: 8952492
[TBL] [Abstract][Full Text] [Related]
14. Peyssonols A and B, two novel inhibitors of the reverse transcriptases of human immunodeficiency virus types 1 and 2.
Loya S; Bakhanashvili M; Kashman Y; Hizi A
Arch Biochem Biophys; 1995 Feb; 316(2):789-96. PubMed ID: 7532386
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human immunodeficiency virus-1 reverse transcriptase activity by rubromycins: competitive interaction at the template.primer site.
Goldman ME; Salituro GS; Bowen JA; Williamson JM; Zink DL; Schleif WA; Emini EA
Mol Pharmacol; 1990 Jul; 38(1):20-5. PubMed ID: 1695317
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones.
Budihas SR; Gorshkova I; Gaidamakov S; Wamiru A; Bona MK; Parniak MA; Crouch RJ; McMahon JB; Beutler JA; Le Grice SF
Nucleic Acids Res; 2005; 33(4):1249-56. PubMed ID: 15741178
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design, synthesis, and in vitro assay of novel nucleoside analog inhibitors against HIV-1 reverse transcriptase.
Liu X; Xie W; Huang RH
Bioorg Med Chem Lett; 2005 Aug; 15(16):3775-7. PubMed ID: 15993595
[TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of inhibition of human immunodeficiency virus type-1 reverse transcriptase by calanolide A.
Currens MJ; Mariner JM; McMahon JB; Boyd MR
J Pharmacol Exp Ther; 1996 Nov; 279(2):652-61. PubMed ID: 8930168
[TBL] [Abstract][Full Text] [Related]
19. Newly synthesized L-enantiomers of 3'-fluoro-modified beta-2'-deoxyribonucleoside 5'-triphosphates inhibit hepatitis B DNA polymerases but not the five cellular DNA polymerases alpha, beta, gamma, delta, and epsilon nor HIV-1 reverse transcriptase.
von Janta-Lipinski M; Costisella B; Ochs H; Hübscher U; Hafkemeyer P; Matthes E
J Med Chem; 1998 Jun; 41(12):2040-6. PubMed ID: 9622545
[TBL] [Abstract][Full Text] [Related]
20. Indolopyridones inhibit human immunodeficiency virus reverse transcriptase with a novel mechanism of action.
Jochmans D; Deval J; Kesteleyn B; Van Marck H; Bettens E; De Baere I; Dehertogh P; Ivens T; Van Ginderen M; Van Schoubroeck B; Ehteshami M; Wigerinck P; Götte M; Hertogs K
J Virol; 2006 Dec; 80(24):12283-92. PubMed ID: 17020946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
